Results 241 to 250 of about 4,399,583 (292)

Risk prediction model for waitlist mortality in patients with left ventricular assist devices. [PDF]

JHLT Open
Tibrewala A, Pham DT, Hu M, Petito LC, Rich JD, Gustafsson F, de By TMMH, Veen K, Lloyd-Jones DM, Shah SJ.   +9 more
europepmc   +1 more source

Carvedilol vs. Metoprolol Effectiveness in Patients With Left Ventricular Assist Devices: A TriNetX Analysis. [PDF]

Cureus
Nwaezeapu KI, Ajenaghughrure G, Essien E, Frimpong S, Aghasili CC, Odukudu GO, Qadri H, Patel YB, Ndakotsu A, Zamani T.   +9 more
europepmc   +1 more source

Management of Ventricular Arrhythmias in Patients with Left Ventricular Assist Devices: Pathophysiology, Risk Stratification, and Ablation Strategies. [PDF]

J Clin Med
Sgarito G, Campo F, Sciacca S, Pilato M, Cipriani M, Conti S.   +5 more
europepmc   +1 more source

Comparative Outcomes Following <i>Candida</i> Bloodstream Infection in Patients With Left Ventricular Assist Devices. [PDF]

Open Forum Infect Dis
Mansoor AE, Krishnan G, Zuniga-Moya JC, Papadopoulus B, Spec A, George I.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Left Ventricular Assist Device in Pregnancy

Obstetrics & Gynecology, 2011
: Left ventricular assist devices have become increasingly common for the treatment of acute and chronic heart failure. It is unclear whether these devices can handle the increased stresses caused by pregnancy.: An 18-year-old woman received a left ventricular assist device after peripartum cardiomyopathy.
Shane, LaRue, Anthony, Shanks, I-Wen, Wang, Gregory, Ewald, Diane, Anderson, Susan, Joseph   +5 more
openaire   +2 more sources

Implantation of the Left Ventricular Assist Device

Journal of Cardiac Surgery, 1987
Development of mechanical devices for support of the failing heart is a major goal in cardiac surgery. The application of left ventricular assist device (LVAD) is a promising approach in the case of severe and otherwise untreatable cardiac failure.
W, Klepetko, E, Wolner
openaire   +2 more sources

Immunobiology of left ventricular assist devices

Progress in Cardiovascular Diseases, 2000
The increasing use of implanted biomaterial devices has made it evident that no material is biologically inert. As a result of direct contact with elements of the blood circulation, such as during hemodialysis or after left ventricular assist device (LVAD) implantation, significant changes in systemic immunologic and thrombostatic functions occur.
S, Itescu, J H, Ankersmit, A A, Kocher, M D, Schuster   +3 more
openaire   +2 more sources